Proteomics International Laboratories
(ASX) PIQ
Proteomics International Laboratories Financials at a Glance
Market Cap
$37.17M
Revenue (TTM)
$3.98M
Net Income (TTM)
$16.77M
EPS (TTM)
$-0.06
P/E Ratio
-3.57
Dividend
$0.00
Beta (Volatility)
-0.00 (Low)
Dividend
$0.00
Beta (Volatility)
-0.00 (Low)
Price
$0.23
Volume
165,368
Open
$0.23
Price
$0.23
Volume
165,368
Open
$0.23
Previous Close
$0.23
Daily Range
$0.21 - $0.23
52-Week Range
$0.21 - $0.86
Dividend
$0.00
Beta (Volatility)
-0.00 (Low)
Price
$0.23
Volume
165,368
Open
$0.23
Previous Close
$0.23
Daily Range
$0.21 - $0.23
52-Week Range
$0.21 - $0.86
PIQ News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Proteomics International Laboratories
Industry
Life Sciences Tools and Services
Sector
Health CareCEO
Richard Lipscombe, PhD
Website
www.proteomics.com.auHeadquarters
Perth, WA 6009, AU
PIQ Financials
Key Financial Metrics (TTM)
Gross Margin
-19%
Operating Margin
-26%
Net Income Margin
-20%
Return on Equity
-150%
Return on Capital
-1%
Return on Assets
-85%
Earnings Yield
-28.01%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$37.17M
Shares Outstanding
165.18M
Volume
165.37K
Short Interest
0.00%
Avg. Volume
489.30K
Financials (TTM)
Gross Profit
$960.39K
Operating Income
$10.62M
EBITDA
$10.00M
Operating Cash Flow
$6.60M
Capital Expenditure
$29.65K
Free Cash Flow
$6.63M
Cash & ST Invst.
$11.04M
Total Debt
$277.74K
Proteomics International Laboratories Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$357.44K
-34.0%
Gross Profit
$5.00M
-58.8%
Gross Margin
-14.00%
N/A
Market Cap
$37.17M
N/A
Market Cap/Employee
$1.00M
N/A
Employees
37
N/A
Net Income
$6.03M
-60.6%
EBITDA
$6.18M
-71.0%
Quarterly Fundamentals
Net Cash
$6.99M
+41.9%
Accounts Receivable
$221.22K
+664.4%
Inventory
$0.00
N/A
Long Term Debt
$454.34K
+4037.9%
Short Term Debt
$227.11K
+541.4%
Return on Assets
-85.45%
N/A
Return on Invested Capital
-1.39%
N/A
Free Cash Flow
$3.01M
-75.5%
Operating Cash Flow
$950.22K
+28.9%